CareRx Corporation (TSX:CRRX)
Canada
· Delayed Price · Currency is CAD 2.760
-0.040 (-1.43%)
May 2, 2025, 3:29 PM EDT
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 366.71 | 370.75 | 381.73 | 262.63 | 162.2 | Upgrade
|
| Revenue Growth (YoY) | -1.09% | -2.88% | 45.35% | 61.92% | 30.15% | Upgrade
|
| Cost of Revenue | 258.65 | 266.05 | 271.79 | 187.35 | 115.14 | Upgrade
|
| Gross Profit | 108.06 | 104.7 | 109.93 | 75.28 | 47.05 | Upgrade
|
| Selling, General & Admin | 101.28 | 97.87 | 102.55 | 70.52 | 47.98 | Upgrade
|
| Operating Expenses | 101.28 | 97.87 | 102.55 | 70.52 | 47.98 | Upgrade
|
| Operating Income | 6.78 | 6.83 | 7.38 | 4.76 | -0.93 | Upgrade
|
| Interest Expense | -8.9 | -13.86 | -14.89 | -14.65 | -9.69 | Upgrade
|
| Interest & Investment Income | 0.06 | 1.26 | 0.28 | 0.06 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.29 | -0.13 | 5.24 | -2.24 | 2.64 | Upgrade
|
| EBT Excluding Unusual Items | -2.34 | -5.91 | -1.98 | -12.08 | -7.92 | Upgrade
|
| Merger & Restructuring Charges | -1.49 | -1.45 | -5 | -8.06 | -11.4 | Upgrade
|
| Impairment of Goodwill | -0.76 | -0.71 | -22.52 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -2.71 | - | 0.76 | Upgrade
|
| Asset Writedown | - | - | -1.81 | - | - | Upgrade
|
| Other Unusual Items | 0.13 | -1.53 | -1.87 | -3.6 | 0.25 | Upgrade
|
| Pretax Income | -4.47 | -9.6 | -35.9 | -23.74 | -18.3 | Upgrade
|
| Income Tax Expense | 0.03 | -4.19 | -1.54 | -1.01 | -0.12 | Upgrade
|
| Earnings From Continuing Operations | -4.5 | -5.41 | -34.35 | -22.73 | -18.18 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -0.08 | Upgrade
|
| Net Income to Company | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 | Upgrade
|
| Net Income | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 | Upgrade
|
| Net Income to Common | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 57 | 48 | 35 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 57 | 48 | 35 | 20 | Upgrade
|
| Shares Change (YoY) | 5.06% | 20.49% | 36.54% | 72.00% | 84.63% | Upgrade
|
| EPS (Basic) | -0.07 | -0.09 | -0.72 | -0.65 | -0.90 | Upgrade
|
| EPS (Diluted) | -0.07 | -0.09 | -0.72 | -0.65 | -0.90 | Upgrade
|
| Free Cash Flow | 32.4 | 22.65 | 12.29 | 1.92 | -1.33 | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.40 | 0.26 | 0.06 | -0.07 | Upgrade
|
| Gross Margin | 29.47% | 28.24% | 28.80% | 28.66% | 29.01% | Upgrade
|
| Operating Margin | 1.85% | 1.84% | 1.93% | 1.81% | -0.57% | Upgrade
|
| Profit Margin | -1.23% | -1.46% | -9.00% | -8.65% | -11.26% | Upgrade
|
| Free Cash Flow Margin | 8.84% | 6.11% | 3.22% | 0.73% | -0.82% | Upgrade
|
| EBITDA | 22.06 | 22.89 | 21.74 | 16.96 | 8.35 | Upgrade
|
| EBITDA Margin | 6.02% | 6.17% | 5.69% | 6.46% | 5.15% | Upgrade
|
| D&A For EBITDA | 15.28 | 16.07 | 14.35 | 12.21 | 9.27 | Upgrade
|
| EBIT | 6.78 | 6.83 | 7.38 | 4.76 | -0.93 | Upgrade
|
| EBIT Margin | 1.85% | 1.84% | 1.93% | 1.81% | -0.57% | Upgrade
|
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.